When the world’s largest condom manufacturer says it has no choice but to pass costs on to customers, every personal care buyer and pharmacy category manager in Australia should be paying attention. A 20 to 30 per cent price increase on a high-volume, high-frequency category is not a rounding error — it’s a margin conversation that’s about to land on a lot of desks.
Malaysia’s Karex Bhd, which produces more than five billion condoms annually, has confirmed it is planning to raise prices by 20 to 30 per cent, with further increases possible if supply chain disruptions tied to the Iran war continue to escalate. CEO Goh Miah Kiat made the announcement in an interview with Reuters, citing rising input costs across synthetic rubber, nitrile, aluminium foil, silicone oil, and packaging materials — virtually every component in the manufacturing process.
What Is Karex and Why It Matters for FMCG Personal Care
Karex is not a brand most shoppers would recognise, but it sits at the centre of the global condom supply chain in a way few manufacturers do in any category. The company supplies finished product to Durex and Trojan — two of the most distributed personal care brands in Australian supermarkets and pharmacies — as well as to the UK’s National Health Service and United Nations aid programmes.
That breadth of customer exposure means a Karex price increase doesn’t stay contained to one channel or one market. It flows through to branded retail, private label, and public health procurement simultaneously. For Australian FMCG buyers, the relevant question is not whether prices will rise, but how quickly that increase moves through the supply chain to shelf.
The Iran War’s Impact on Condom Supply Chains
Since the conflict began in late February, Karex has faced cost increases across nearly every input category. Synthetic rubber and nitrile — core materials in latex and non-latex condom manufacturing — are sourced from petrochemical supply chains that run through or adjacent to the Middle East. The Iran war has strained energy and petrochemical flows from the region, pushing raw material costs higher across the board.
Shipping timelines have also blown out. Karex’s shipments to Europe and the United States, which previously took around one month, are now taking close to two months. That delay is compounding a stockpile problem that was already developing before the conflict escalated. Goh noted that a significant number of condoms are currently sitting on vessels that have not yet reached their destination, while demand at the receiving end continues to build.
Demand for condoms has risen approximately 30 per cent this year, according to Goh. That surge is partly driven by the shipping disruptions themselves — customers are ordering more to compensate for longer lead times and thinner safety stock — and partly by a structural gap created when the United States Agency for International Development (USAID) made deep cuts to foreign aid spending last year, reducing global stockpile buffers that had previously absorbed supply shocks.
Price Increase Breakdown: What Buyers Are Facing
| Input Category | Disruption Driver | Impact on Karex |
|---|---|---|
| Synthetic rubber / nitrile | Petrochemical supply disruption, Middle East | Higher raw material cost |
| Aluminium foil / packaging | Freight delays, energy cost increases | Higher packaging cost |
| Silicone oil (lubricant) | Supply chain bottlenecks | Higher input cost |
| Ocean freight | Shipping route disruptions | Transit time doubled to ~2 months |
| Finished goods inventory | USAID aid cuts, demand surge | Global stockpiles significantly reduced |
What This Does Not Change
Karex has confirmed it holds enough raw material supplies for the next few months, which means the immediate production risk is contained for now. The price increases flagged are forward-looking, not a signal of imminent product shortages at retail in the near term.
The increases also apply at the manufacturer level. How much of that cost lands on shelf will depend on individual retailer negotiations, private label contract structures, and whether branded suppliers like Reckitt — which owns Durex — absorb any portion of the increase. Australian pharmacy and grocery buyers will have their own contractual positions to work through before any consumer price movement becomes visible.
Who Benefits and When
Retailers with strong private label positions in personal care have some flexibility here — they can negotiate directly with manufacturers and potentially hold price longer than branded competitors. Distributors and wholesalers who locked in forward contracts before the conflict escalated are also better positioned. The pressure falls hardest on smaller pharmacy chains and independent retailers who lack the volume to negotiate cost-sharing arrangements with suppliers.
Where This Fits in the Broader FMCG Supply Chain Story
Karex is not alone. The company’s situation mirrors what medical glove manufacturers are already navigating — a category built on petrochemical inputs, concentrated in Southeast Asian production, and exposed to Middle Eastern supply disruptions. For Australian FMCG professionals, this is a reminder that geopolitical risk is no longer an abstract line item in a risk register. It’s showing up in freight invoices, raw material quotes, and supplier price notifications right now.
The personal care category has been relatively stable on price compared to food and beverage over the past two years. That stability is now under pressure from a direction most category plans didn’t model — a regional conflict affecting petrochemical supply chains, compounded by the withdrawal of a major global aid buyer that had previously kept manufacturer volumes and margins predictable.
If you’re managing a personal care category or running procurement for a pharmacy or grocery chain, now is the time to review your Karex-adjacent supplier contracts, stress-test your safety stock assumptions, and have a frank conversation with your trading partners about where the cost increase lands — because it is coming, and the timeline is shorter than the shipping delays suggest.